WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017197525) PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION THERAPY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/197525 International Application No.: PCT/CA2017/050605
Publication Date: 23.11.2017 International Filing Date: 18.05.2017
IPC:
C12N 7/01 (2006.01) ,A61K 35/766 (2015.01) ,A61K 39/00 (2006.01) ,A61K 45/06 (2006.01) ,A61P 35/00 (2006.01) ,C07K 14/145 (2006.01) ,C12N 15/40 (2006.01) ,C12N 15/47 (2006.01) ,C12N 15/86 (2006.01)
Applicants: EVGIN, Laura[CA/CA]; CA
Inventors: EVGIN, Laura; CA
Agent: NAUMAN, David; CA
KEELER, Todd; CA
DE KLEINE, Geoffrey; CA
ALLARD, Louis; CA
BEHMANN, Curtis B.; CA
BOOCOCK, Graeme; CA
COGHLAN, Jeffrey; CA
COLLARD, Christine J.; CA
CONN, David L.; CA
EVENSON, Brandon; CA
FRITZ, Joachim T.; CA
GORDON, Jeffrey Keith; CA
HOWG, Jason L.; CA
HUNG, Shin H.; CA
MARSMAN, Kathleen E.; CA
MUELLER-NEUHAUS, Jason; CA
PUNDSACK, Scott R.; CA
RAOUL, Jennifer M.; CA
SILVER, Gail C.; CA
SOJONKY, Andrew D.; CA
VICKERS, Mark F.; CA
WEBB, Tim E.; CA
WOOD, David; CA
ZIMMERMAN, Gordon; CA
Priority Data:
62/338,94019.05.2016US
Title (EN) PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION THERAPY
(FR) RHABDOVIRUS ONCOLYTIQUES PSEUDOTYPÉS ET LEUR UTILISATION EN POLYTHÉRAPIE
Abstract: front page image
(EN) Embodiments of the invention include compositions and methods related to replicative oncolytic rhabdoviruses pseudotyped with an arenavirus glycoprotein and their use as anti-cancer therapeutics particularly in combination with complement inhibitors.
(FR) Des modes de réalisation de l'invention comprennent des compositions et des méthodes associées à des rhabdovirus oncolytiques réplicatifs pseudotypés avec une glycoprotéine d'arénavirus et leur utilisation en tant qu'agents thérapeutiques anticancéreux, en particulier en combinaison avec des inhibiteurs du complément.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)